0001171000-15-000108.txt : 20151124
0001171000-15-000108.hdr.sgml : 20151124
20151124153751
ACCESSION NUMBER: 0001171000-15-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151123
FILED AS OF DATE: 20151124
DATE AS OF CHANGE: 20151124
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nexvet Biopharma plc
CENTRAL INDEX KEY: 0001618561
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
BUSINESS PHONE: 353 1 215 8100
MAIL ADDRESS:
STREET 1: UNIT 5, SRAGH TECHNOLOGY PARK
STREET 2: RAHAN ROAD
CITY: TULLAMORE , CO. OFFALY
STATE: L2
ZIP: R35 FR98
FORMER COMPANY:
FORMER CONFORMED NAME: NEXVET BIOPHARMA Ltd
DATE OF NAME CHANGE: 20140903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lismore Damian T.
CENTRAL INDEX KEY: 0001560864
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36828
FILM NUMBER: 151252578
MAIL ADDRESS:
STREET 1: 12270 WILKINS AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20852
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-11-23
0001618561
Nexvet Biopharma plc
NVET
0001560864
Lismore Damian T.
C/O NEXVET BIOPHARMA PLC
UNIT 5, SRAGH TECHNOLOGY PARK,RAHAN ROAD
TULLAMORE , CO. OFFALY
L2
R35 FR98
IRELAND
0
1
0
0
CHIEF FINANCIAL OFFICER
Ordinary Shares
2015-11-23
4
M
0
6000
.125
A
16000
D
Ordinary Shares
14160
I
By spouse
Ordinary Shares
13724
I
Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C>
Option to Purchase Shares
.125
2015-11-23
4
M
0
6000
0
D
2019-07-01
Ordinary Shares
6000
8000
D
The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
6,000 options to purchase shares vested and became exercisable on 11/19/15 after the Issuer's board of directors determined that there had been successful completion of an efficacy trial for an Issuer product. A further 4,000 options to purchase shares will vest and become exercisable on each of 7/1/16 and 7/1/17.
/s/ Damian Lismore by Geraldine T. Farrell, Attorney-in-Fact
2015-11-23